The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full deta clinical trials
4 indexed studies · 0 currently recruiting
- Completed
Multimodal Augmented Reality for Operative Guidance in Interventional Neuroradiology
This UK clinical study is testing whether augmented reality (AR) technology can assist doctors during delicate brain and blood vessel procedures. The full study details are temporarily private under official UK regulations, but they will be published openly within 30 months after the research finishes.
For: The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.United Kingdom · England - Completed
A Phase 1 trial: Fortrea Phase 1 Leeds Clinic: SUDO-550-101
This early-stage study, called Fortrea Phase 1 Leeds Clinic: SUDO-550-101, is taking place in Leeds. The full details about what the study is looking for and who can join will be publicly shared up to 30 months after it finishes. We don't have more information yet.
For: The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.United Kingdom · England - Completed
A Phase 1 trial: MEU Phase 1 Clinic: SUDO-286-102
This early-stage study is a medical trial where the details are not yet fully public. They will be shared within 30 months after the study finishes. It's designed to gather initial information about something new, but specifics are currently confidential.
For: The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.United Kingdom · England - Completed
Phase 1 trial: Fortrea CRU code: 8526072
This early-stage study is looking for healthy men to help test a new treatment. We don't have all the details yet, but the aim is to check if it's safe. Information will be made public later.
For: The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.United Kingdom · England